Prevalence of cystoid macular oedema, epiretinal membrane and cataract
| By patient, N (%) | By eye, N (%) | |
| All patients | 169 | 338 |
| Cystoid macular oedema | 99 (58.6) | 172 (50.9) |
| Bilateral | 73 (73.7) | – |
| Untreated | 31 (31.3) | 53 (30.8) |
| Oral acetazolamide | 37 (37.4) | 68 (39.5) |
| Topical dorzolamide | 29 (29.3) | 49 (28.5) |
| Past treatment | 2 (2.0) | 2 (1.2) |
| Epiretinal membrane | 43 (25.4) | 77 (22.8) |
| Bilateral | 34 (79.1) | – |
| Cataract | 46 (27.2) | 79 (23.4) |
| Bilateral | 33 (71.7) | – |
| Pseudophakia | 20 (11.8) | 38 (11.2) |
| Bilateral | 19 (95.0) | – |